Global Assisted Reproductive Technology Market Size, Forecast | USD 56.18 Billion by 2028

September 22nd, 2022 Releases

Global Assisted Reproductive Technology Market is valued at USD 28.94 Billion in 2021 and is expected to reach USD 56.18 Billion by 2028 with a CAGR of 9.94% over the forecast period.

Scope of Global Assisted Reproductive Technology Market:

ART (assisted reproductive technology), primarily an uncontrolled multi-billion-dollar industry is the only type of medical treatment that has the “ultimate goal” of creating another person. Basic ART (assisted reproductive technology) involves dietary changes, lifestyle changes, and medication or hormone therapy, and approximately 85% of infertility cases are treated with these measures. Additionally, more sophisticated, and invasive interventions include intrauterine insemination (IUI) and in vitro fertilization (IVF). Intrauterine insemination (IUI) is a relatively simple nonsurgical procedure in which sperm produced by a partner or donor is inserted into a woman’s uterus during her ovulatory phase and brought closer to the ovum. In vitro fertilization (IVF) is a more complicated procedure in which the ovum is removed from a woman’s body by laparoscopy, fertilized by her spouse’s or donor’s semen, incubated in a laboratory dish until the embryo develops, and then transferred to the woman’s uterus. Some couples may also need a gamete intrafallopian transfer or zygote intrafallopian transfer.

Request Sample PDF @ https://brandessenceresearch.com/requestSample/PostId/1836

Some of the key players/Manufacturers involved in the Assisted Reproductive Technology Market are:

  • Cook Medical Inc.
  • Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
  • Genea Biomedx, Merck KGaA (EMD Serono, Inc.)
  • Millendo Therapeutics, Inc.
  • Oxford Gene Technology
  • Progyny Inc.
  • The Cooper Companies, Inc. (CooperSurgical, Inc.)
  • Thermo Fisher Scientific, Inc.
  • Vitrolife AB
  • others

Global Assisted Reproductive Technology Market Segmentation Analysis:

By Product:

  • Instrument (Sperm Separation System, Cryptosystem, Incubator, Imaging System, Ovum Aspiration Pump, Cabinet, Micromanipulator, Laser Systems, Others)
  • Accessory & Disposable
  • Reagents & Media (Cryopreservation Media, Semen Processing Media, Ovum Processing Media, Embryo Culture Media)

By Technology:

  • In Vitro-Fertilization
  • Artificial Insemination
  • Others

By End-User:

  • Fertility Clinic
  • Hospital
  • Surgical Center
  • Clinical Research Institute

News: Silverfleet Capital Invested in Leading UK Fertility Group CARE Fertility

On August 24th, 2020; Silver fleet Capital, a Pan-European private equity firm, entered into a binding agreement with CARE Fertility Holdings Limited (CARE or Company) on April 25, 2019 to acquire a majority stake. Headquartered in Nottingham, England, the company is the UK’s leading breeding service provider with a strong scientific and clinical backbone. The terms of the transaction were not disclosed.

Buy Now @ https://brandessenceresearch.com/Checkout?report_id=1836

Global Assisted Reproductive Technology Market Dynamics:

The growth of the global assisted reproductive technology market is largely driven by rising number of cases of infertility rates; increased funding from private and government agencies for infertility services; rising awareness about infertility treatment and surrogacy; and an increase in technology in auxiliary reproductive technology. According to the World Health Organization (WHO); by 2020, an estimated 186 million individuals and 48 million couples have been diagnosed with infertility. According to the Centers for Disease Control and Prevention (CDC), approximately six percent to 12 percent of U.S. women with PCOS were also diagnosed with infertility. The Brandessence report estimates that one in six American couples experiences infertility at some point and about 14 percent of married couples who have not been surgically sterilized experience infertility in any given year. More precisely, nine out of every 100 women worldwide between the ages of 20 and 44 cannot conceive. As Dave Shed states, “Because disability only has a neutral or negative effect on fertility, people with disabilities are just as likely as or more likely to experience infertility than people with disabilities. Thus, it is expected that at least fourteen percent of heterosexual couples trying to conceive, with at least one partner having a disability, are infertile in any year, and at least one-sixth of such couples will experience infertility at some point in their relationship. An estimated 7.3 million couples in the United States are currently experiencing infertility.

On Special Requirement Assisted Reproductive Technology Market Report is also available for below region:

North America

  • S., Canada

Europe

  • Germany, France, U.K., Italy, Spain, Sweden, Netherlands, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

  • South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC

Latin America

  • Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

  • Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA

Key Questions This Study Will Answer:

  • What is the scope of growth in the Assisted Reproductive Technology market?
  • What is the core strategy for growth in the Assisted Reproductive Technology market?
  • What is the promise of growth in the long run?
  • What is the promise of growth during the forecast period?
  • How big is the Assisted Reproductive Technology market?
  • What are the main opportunities for growth in the Assisted Reproductive Technology market?
  • What are the key regions for future investments?
  • What is the scope of growth in a particular country/ region of my interest?
  • What are the risks involved in investing in the Assisted Reproductive Technology market?
  • Who are the key players in the Assisted Reproductive Technology market?
  • What are the core strategies of key players in the Assisted Reproductive Technology market?

 

Browse Full and Sample Report Description Along with TOC & List of Facts & Figures Here

 

Other Trending Reports:

I-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister

 

Brandessence Market Research & Consulting Pvt ltd.

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Follow Us: LinkedIn

Contact:

Email: vishal@brandessenceresearch.com

Email: Sales@brandessenceresearch.com

Corporate Sales: +44-2038074155

Asia Office: +917447409162

© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.